'A challenging study of where America went wrong in the war on drugs. Even those who disagree will have to take notice of this well-argued book.'-John DiIulio, Woodrow Wilson School of Public and International Affairs, Princeton University

Since the mid-1980s subsequent US governments have promoted a highly militarized and prohibitionist drug control approach in Latin America. Despite this strategy the region has seen increasing levels of homicide, displacement and violence. Why did the militarization of U.S. drug war policies in Latin America begin and why has it continued despite its inability to achieve the stated targets? Are such policies simply intended to impose U.S. power or have elites in Latin America internalized this agenda as their own? Why did resistance to this approach emerge in the late-2000s and does this represent a challenge to the prohibitionist agenda? In this book William Avilés argues that if we are to understand and explain the militarization of the drug war in Latin America a ‘transnational grand strategy’, developed and implemented by networks of elites and state managers operating in a neoliberal, globalized social structure of accumulation, must be considered and examined.

A balanced and sophisticated analysis of the true costs, benefits, and consequences of enforcing drug prohibition is presented in this book. Miron argues that prohibition's effects on drug use have been modest and that prohibition has numerous side effects, most of them highly undesirable. In particular, prohibition is shown to directly increase violent crime, even in cases where it deters drug use. Miron's analysis leads to a disturbing finding—the more resources given to the fight against drugs, the greater the homicide rate. The costs and benefits of several alternatives to the war on drugs are examined. The conclusion is unequivocal and states that any of the most widely discussed alternatives is likely to be a substantial improvement over current policy.

Table of contents

Despite efforts to reduce drug consumption in the United States over the past 35 years, drugs are just as cheap and available as they have ever been. Cocaine, heroin, and methamphetamines continue to cause great harm in the country, particularly in minority communities in the major cities. Marijuana use remains a part of adolescent development for about half of the country's young people, although there is controversy about the extent of its harm. Given the persistence of drug demand in the face of lengthy and expensive efforts to control the markets, the National Institute of Justice asked the National Research Council to undertake a study of current research on the demand for drugs in order to help better focus national efforts to reduce that demand. This study complements the 2003 book, Informing America's Policy on Illegal Drugs by giving more attention to the sources of demand and assessing the potential of demand-side interventions to make a substantial difference to the nation's drug problems. Understanding the Demand for Illegal Drugs therefore focuses tightly on demand models in the field of economics and evaluates the data needs for advancing this relatively undeveloped area of investigation.

Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.

Picking his way through Andean cocaine fields, Central American prisons, Colorado pot shops, and the online drug dens of the Dark Web, Tom Wainwright provides a fresh, innovative look into the drug trade and its 250 million customers. More than just an investigation of how drug cartels do business, Narconomics is also a blueprint for how to defeat them. How does a budding cartel boss succeed (and survive) in the 300 billion illegal drug business? By learning from the best, of course. From creating brand value to fine-tuning customer service, the folks running cartels have been attentive students of the strategy and tactics used by corporations such as Walmart, McDonald's, and Coca-Cola. And what can government learn to combat this scourge? By analyzing the cartels as companies, law enforcers might better understand how they work -- and stop throwing away 100 billion a year in a futile effort to win the "war" against this global, highly organized business. Your intrepid guide to the most exotic and brutal industry on earth is Tom Wainwright. Picking his way through Andean cocaine fields, Central American prisons, Colorado pot shops, and the online drug dens of the Dark Web, Wainwright provides a fresh, innovative look into the drug trade and its 250 million customers. The cast of characters includes "Bin Laden," the Bolivian coca guide; Old Lin," the Salvadoran gang leader; "Starboy," the millionaire New Zealand pill maker; and a cozy Mexican grandmother who cooks blueberry pancakes while plotting murder. Along with presidents, cops, and teenage hitmen, they explain such matters as the business purpose for head-to-toe tattoos, how gangs decide whether to compete or collude, and why cartels care a surprising amount about corporate social responsibility. More than just an investigation of how drug cartels do business, Narconomics is also a blueprint for how to defeat them.